Helicobacter pylori: bacteriological aspects, diagnostic methods, and susceptibility to antibiotics;Helicobacter pylori : caractères bactériologiques, méthodes diagnostiques et sensibilité aux antibiotiques

Presse Medicale

Volumn 37, Issue 3 PART 2, 2008, Pages 507-512

  Mégraud, Francis ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; HELICOBACTER PYLORI; LUNG FUNCTION TEST; NONHUMAN; PATHOGENICITY; PREVALENCE; SEROLOGY; SHORT SURVEY; DRUG EFFECT; HELICOBACTER INFECTION; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; REVIEW;

ANTI-BACTERIAL AGENTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 41649112551     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2007.07.033     Document Type: Short Survey

References (19)

1. J.R. Warren B. Marshall Unidentified curved bacilli on gastric epithelium in active chronic gastritis Lancet 1 1983 1273 1275
2. P. Vandamme E. Falsen R. Rossau B. Hoste P. Segers R. Tytgat Revision of Campylobacter , Helicobacter , and Wolinella taxonomy: emendation of generic descriptions and proposal of Arcobacter gen. nov Int J Syst Bacteriol 41 1991 88 103
3. G.M. Garrity J.A. Belle T. Lilburn Family III. Helicobacteraceae fam. nov 2nd ed. Bergey's Manual of Determinative Bacteriology 2 2005 Springer New York 1168 1194
4. H.R. Koelz Gastric acid in vertebrates Scand J Gastroenterol Suppl 193 1992 2 6
5. D.J. McGee C.A. May R.M. Garner J.M. Himpsl H.L.T. Mobley Isolation of Helicobacter pylori genes that modulate urease activity J Bacteriol 181 1999 2477 2484
6. M. Hatakeyama H. Higashi Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis Cancer Sci 96 2005 835 843
7. J. Viala C. Chaput I.G. Boneca A. Cardona S.E. Girardin A.P. Moran Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island Nat Immunol 5 1994 1166 1174
8. A. Galmiche J. Rassow A. Doye S. Cagnol J.C. Chambard S. Contamin The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release Embo J 19 2000 6361 6370
9. D. Falush T. Wirth B. Linz J.K. Pritchard M. Stephens M. Kidd Traces of human migrations in Helicobacter pylori populations Science 299 2003 1582 1585
10. B. Linz F. Balloux Y. Moodley A. Manica H. Liu P. Roumagnac An African origin for the intimate association between humans and Helicobacter pylori Nature 445 2007 915 918
11. F. Megraud P. Lehours Helicobacter pylori diagnosis and antimicrobial susceptibility testing Clin Microbiol Rev 20 2007 280 322
12. M. Oleastro A. Ménard A. Santos H. Lamouliatte L. Monteiro C. Barthélémy Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori J Clin Microbiol 41 2003 397 402
13. C. Schabereiter Gurtner A.M. Hirschl B. Dragosics P. Hufnagl S. Puz Z. Kovach Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens J Clin Microbiol 42 2004 4512 4518
14. L. Monteiro A. de Mascarel A.M. Sarrasqueta B. Bergey C. Barberis P. Talby Diagnosis of Helicobacter pylori infection: noninvasive methods compared to invasive methods and evaluation of two new tests Am J Gastroenterol 96 2001 353 358
15. N. Broutet S. Tchamgoué E. Periera H. Lamouliatte R. Salamon F. Mégraud Risk factors for failure of Helicobacter pylori therapy - results of an individual data analysis of 2751 patients Aliment Pharmacol Ther 17 2003 99 109
16. P. Malfertheiner F. Megraud C. O’Morain F. Bazzoli E. El-Omar D. Graham Current concepts in the management of Helicobacter pylori infection - The Maastricht III Consensus Report Gut 56 2007 772 781
17. F. Mégraud H pylori antibiotic resistance: prevalence, importance, and advances in testing Gut 53 2004 1374 1384
18. N. Vakil F. Mégraud Eradication therapy for Helicobacter pylori Gastroenterology 133 2007 985 1001
19. B. Grignon J. Tankovic F. Megraud Y. Glupczynski M.O. Husson M.C. Conroy Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori Microb Drug Resist 8 2002 61 66